Atlas Private Wealth Advisors Kiromic Biopharma, Inc. Transaction History

Atlas Private Wealth Advisors

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Apr 28, 2021	SELL	$8.2 - $11.81 $16,400 - $23,620	-2,000 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$8.11 - $11.5 $16,219 - $23,000	2,000 New	2,000 $17,000

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $16M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of Atlas Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Atlas Private Wealth Advisors with notifications on news.